KYNTRA BIO, INC. (KYNB) Operating margin 2016–2025
KYNTRA BIO, INC. (KYNB) operating margin by fiscal year — reported operating income divided by reported revenue.
-712.7%FY2025 · since FY2016: -27.3% → -712.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -712.7% | -204.9 pp |
| FY2024 | -507.8% | +181.7 pp |
| FY2023 | -689.5% | -475.6 pp |
| FY2022 | -213.9% | -91.3 pp |
| FY2021 | -122.6% | -13.8 pp |
| FY2020 | -108.8% | -74.0 pp |
| FY2019 | -34.8% | +5.9 pp |
| FY2018 | -40.7% | +48.8 pp |
| FY2017 | -89.5% | -62.2 pp |
| FY2016 | -27.3% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More KYNB financial trends
KYNB RevenueKYNB Net incomeKYNB Net marginKYNB Gross profitKYNB Gross marginKYNB Operating incomeKYNB Operating cash flowKYNB Free cash flowKYNB Capital expendituresKYNB Return on equityKYNB Stock buybacksKYNB Dividends paidKYNB Total assetsKYNB Total liabilitiesKYNB Shareholders’ equityKYNB overview →